We’re excited to invite North East Lincolnshire locals to walk inside a giant inflatable bowel to raise awareness of bowel cancer and its symptoms.

In 2023 we launched our bold new five-year strategy 'On a Mission', we knew it was ambitious, but achievable. Today we’ve published our Annual Report and Accounts 2024, and it’s clear the year marks a ...

NICE has approved the use of the drug fruquintinib (Fruzaqla) for eligible advanced bowel cancer patients living in England and Wales.

The Government has published its 10 Year Health Plan, following a consultation to shape the future of the NHS in England.

The results of the Cancer Prevention Project 3 (CaPP3) trial, a study changing how we think about aspirin and cancer prevention for people with Lynch syndrome.

Bowel cancer is rising fast in under-50s. We're helping drive UK and global research to understand why — and what we can do to stop it.

Low anterior resection syndrome is a collection of bowel symptoms that can happen after surgery to remove all or part of your rectum.

Pelvic exenteration is a major operation that takes out some or all of the organs inside the pelvis. Find out more.

Mr Jones, lead investigator for a trial looking at giving personalised cancer vaccines to people with bowel cancer, tells us more about this new treatment.

Mr Robert Jones has been appointed as the UK’s first Surgical Specialty Lead in Colorectal Liver Metastases.

We're delighted to announce our groundbreaking campaign has been named Corporate National Partnership of the Year with a Retailer at the Charity Times Awards 2023.

Our new five-year strategy sets out how we'll continue to work relentlessly towards our vision of a future where nobody dies from bowel cancer. Our Chief Executive Officer Genevieve Edwards tells us ...